Tolerance Study of the Dietary Supplement Lipidrive (ECPH1-03)

NCT03052062 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Valbiotis

Collaborators